An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia
Kotaro Sakamoto(Ichimaru Pharcos (Japan)), Yukio Ago(Hiroshima University), Naoki Nishizawa(Nissan Chemical Corporation (Japan)), Hideki Shiba(Hiroshima University), S Asano(Hiroshima University), Daisuke Sugiyama, Daichi Koan(Hiroshima University), Rei Yokoyama(The University of Osaka), Bangzhong Lin(The University of Osaka), Runa Fujimoto(Ichimaru Pharcos (Japan)), Rika Ishimura(The University of Osaka), Kazuto Nunomura(The University of Osaka), Shinsaku Nakagawa(The University of Osaka), Zihao Jin(University of Hong Kong)
Cited by 0